Search Results - "Vanderbist, F"

Increased Susceptibility of Pseudomonas aeruginosa to Macrolides and Ketolides in Eukaryotic Cell Culture Media and Biological Fluids Due to Decreased Expression of oprM and Increased Outer-Membrane Permeability by Buyck, Julien M., Plésiat, Patrick, Traore, H., Vanderbist, F., Tulkens, Paul M., Van Bambeke, Françoise

“…Background. Macrolides show high minimum inhibitory concentrations (MICs) against Pseudomonas aeruginosa when tested in recommended media (cation-adjusted…”
Get full text

Development and evaluation of new multiple-unit levodopa sustained-release floating dosage forms by Goole, J., Vanderbist, F., Amighi, K.

“…This work relates to the development and the in vitro evaluation of sustained-release minitablets (MT), prepared by melt granulation and subsequent…”
Get full text

New levodopa sustained-release floating minitablets coated with insoluble acrylic polymer by Goole, J., Deleuze, Ph, Vanderbist, F., Amighi, K.

“…The aim of this study was to develop a new coated multiple-unit sustained-release floating system that is able to float over an extended period of time…”
Get full text

Pharmacoscintigraphic and pharmacokinetic evaluation on healthy human volunteers of sustained-release floating minitablets containing levodopa and carbidopa by Goole, J., Van Gansbeke, B., Pilcer, G., Deleuze, Ph, Blocklet, D., Goldman, S., Pandolfo, M., Vanderbist, F., Amighi, K.

“…In this study, scintigraphic and pharmacokinetic studies were conducted on 10 healthy, fed volunteers. Two concepts of sustained-release floating minitablets –…”
Get full text

Pharmacokinetic evaluation of a new oral sustained release dosage form of tramadol by Malonne, H., Sonet, B., Streel, B., Lebrun, S., De Niet, S., Sereno, A., Vanderbist, F.

“…Aims To compare the pharmacokinetic profile of a new modified release formulation of tramadol (Tramadol LP 200 mg, SMB Technology, Marche‐en‐Famenne, Belgium)…”
Get full text

The effect of combined tobramycin-clarithromycin on Mycobacterium tuberculosis isolates [Technical note] by Stoffels, K, Traore, H, Vanderbist, F, Fauville-Dufaux, M

“…This study investigated the susceptibility of 25 Mycobacterium tuberculosis clinical isolates to tobramycin (TBM) and clarithromycin (CLM). The effect of the…”
Get full text

Evaluation and Floating Enhancement of Levodopa Sustained Release Floating Minitablets Coated with Insoluble Acrylic Polymer by Goole, J., Amighi, K., Vanderbist, F.

“…This article describes the in vitro evaluation and the enhancement of the floating properties of coated sustained release (SR) minitablets (MTs). The evaluated…”
Get full text

Efficacy and tolerability of sustained-release tramadol in the treatment of symptomatic osteoarthritis of the hip or knee: A multicenter, randomized, double-blind, placebo-controlled study by MALONNE, Hugues, COFFINER, Monte, SONET, Bernard, SERENO, Antoine, VANDERBIST, Francis

“…Opioid analgesics may be a useful alternative in patients with osteoarthritis who have not responded to first-line treatment with acetaminophen and in whom…”
Get full text

Long-term tolerability of tramadol LP, a new once-daily formulation, in patients with osteoarthritis or low back pain by Malonne, H., Coffiner, M., Fontaine, D., Sonet, B., Sereno, A., Peretz, A., Vanderbist, F.

“…Summary Introduction:  Tramadol hydrochloride is a centrally acting analgesic, which possesses opioid agonist properties and activates monoaminergic spinal…”
Get full text

TREATMENT OF ALCOHOLIC POLYNEUROPATHY WITH VITAMIN B COMPLEX: A RANDOMISED CONTROLLED TRIAL by PETERS, T. J., KOTOWICZ, J., NYKA, W., KOZUBSKI, W., KUZNETSOV, V., VANDERBIST, F., DE NIET, S., MARCEREUIL, D., COFFINER, M.

“…Aims: To evaluate the therapeutic efficacy and safety of BEFACT® Forte ‘new formulation’ and BEFACT® Forte ‘old formulation’ in the treatment of sensory…”
Get full text

Significance of the biopharmaceutical properties of tramadol sustained-release formulations for chrono-pharmacologically optimized treatment of pain from various sources by Warnke, A, Schug, B, Vanderbist, F, Erbist, Blume, H

“…Tramadol is currently one of the most frequently used opioid analgesics in the world. The objective of this study was to investigate the rate and extent of…”
Get full text

Dose-finding and 24-h monitoring for efficacy and safety of aerosolized Nacystelyn in cystic fibrosis by App, E.M, Baran, D, Dab, I, Malfroot, A, Coffiner, M, Vanderbist, F, King, M

“…The aim of the present studies was to investigate the tolerability and activity of a novel mucolytic drug, Nacystelyn (NAL), for the treatment of cystic…”
Get full text

Performance of the ARES recoil separator for (p,γ) reaction measurements by Couder, M, Angulo, C, Galster, W, Graulich, J.-S, Leleux, P, Lipnik, P, Tabacaru, G, Vanderbist, F

“…In Louvain-la-Neuve, the Astrophysics REcoil Separator (ARES), was installed to measure (p,γ) reactions of astrophysical interest induced by radioactive beams…”
Get full text

Realization and analysis of He-implanted foils for the measurement of (α,γ) reaction cross-sections in nuclear astrophysics by Vanderbist, F., Angulo, C., Couder, M., El Masri, Y., Leleux, P., Loiselet, M., Tabacaru, G.

“…Thin Al foils of 50 μg/cm 2 thickness were implanted with 4He ions with fluences ranging between 10 17 and 10 18 atoms/cm 2. The bulk He contents was measured…”
Get full text

Optimization of a Dry Powder Inhaler Formulation of Nacystelyn, a New Mucoactive Agent by VANDERBIST, F., WERY, B., MOYANO-PAVON, I., MOËS, A. J.

“…The aim of this study was to optimize a dry powder inhaler formulation containing a new mucoactive drug, nacystelyn. Formulations were made using three types…”
Get full text

Effect of the Mucoactive Drug Nacystelyn on the Respiratory Burst of Human Blood Polymorphonuclear Neutrophils by Nagy, A.M, Vanderbist, F, Parij, N, Maes, P, Fondu, P, Nève, J

“…In lung diseases such as chronic obstructive pulmonary disease (COPD) or cystic fibrosis, the activation of phagocytic cells produces high amounts of cytotoxic…”
Get full text

First results with the recoil separator ARES by Angulo, C., Couder, M., Cherubini, S., Galster, W., Graulich, J.-S., Leleux, P., Vanderbist, F., Shotter, A.C.

Get full text

Deposition of Nacystelyn from a Dry Powder Inhaler in Healthy Volunteers and Cystic Fibrosis Patients by Vanderbist, F., Wery, B., Baran, D., Van Gansbeke, B., Schoutens, A., Moës, A. J.

“…The aim of this study was to compare, using gamma scintigraphy, the lung deposition of a novel mucoactive agent, Nacystelyn (NAL), administered as a dry powder…”
Get full text

Preparation and characterization of spray-dried tobramycin powders containing nanoparticles for pulmonary delivery by Pilcer, Gabrielle, Vanderbist, Francis, Amighi, Karim

“…Using high-pressure homogenization and spray-drying techniques, novel formulations were developed for manufacturing dry powder for inhalation, composed of a…”
Get full text

New inhalation-optimized itraconazole nanoparticle-based dry powders for the treatment of invasive pulmonary aspergillosis by Duret, Christophe, Wauthoz, Nathalie, Sebti, Thami, Vanderbist, Francis, Amighi, Karim

“…Itraconazole (ITZ) dry powders for inhalation (DPI) composed of nanoparticles (NP) embedded in carrier microparticles were prepared and characterized. DPIs…”
Get full text